Previous Article | Next Article 
Infection and Immunity, August 2005, p. 4895-4904, Vol. 73, No. 8
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.8.4895-4904.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Comparison of Helicobacter pylori Virulence Gene Expression In Vitro and in the Rhesus Macaque
Jenni K. Boonjakuakul,1,2*
Don R. Canfield,3 and
Jay V. Solnick1,2,4
Departments of Medical Microbiology and Immunology,1
Internal Medicine,2
California National Primate Research Center,3
Center for Comparative Medicine, University of California at Davis, Davis, California 956164
Received 24 September 2004/
Returned for modification 27 December 2004/
Accepted 23 March 2005

ABSTRACT
We used a quantitative real-time reverse transcriptase PCR assay
to measure the transcript abundance of 46 known and putative
Helicobacter pylori virulence genes, including 24 genes on the
Cag pathogenicity island. The expression profile of
H. pylori cells grown in vitro was also compared to expression in vivo
after experimental infection of rhesus macaques. Transcript
abundance in vitro (mid-log phase) ranged from about 0.004 (
feoB and
hpaA) to 20 (
ureAB,
napA, and
cag25) copies/cell. Expression
of most genes was repressed during the transition from logarithmic-
to stationary-phase growth, but several well-characterized
H. pylori virulence genes (
katA,
napA,
vacA, and
cagA) were induced.
Comparison of results in the rhesus macaque with similar data
from humans showed a strong correlation (
r = 0.89). The relative
in vivo expression in the rhesus monkey was highly correlated
with in vitro expression during mid-log (
r = 0.89)- and stationary
(
r = 0.88)-phase growth. Transcript abundance was on average
three- to fourfold reduced in vivo compared to in vitro during
mid-log phase. However, when compared to stationary phase, increased
expression in vivo was observed for 6 of 7 genes on a contiguous
portion of the pathogenicity island, several of which are thought
to encode the
H. pylori type IV structural pilus and its accessory
proteins. These results suggest the possibility that some genes
encoding the
H. pylori type IV structural pilus and accessory
proteins may form an operon that is induced during growth in
vivo.

INTRODUCTION
Helicobacter pylori is a human pathogen that infects nearly
half the world's population and produces a chronic infection
that can lead to gastric and duodenal ulcers, gastric cancer,
and B-cell mucosa-associated lymphoid tissue lymphoma (
40).
While most infected individuals show no signs or symptoms, approximately
10 to 15% will develop
H. pylori-associated disease. More than
half of the
H. pylori strains found in the United States carry
a 37-kb Cag pathogenicity island (PAI), which is more often
found in isolates from patients with peptic ulcer disease, gastric
cancer, or gastric lymphoma than in those with asymptomatic
infection (
2,
12). The Cag PAI genes encode a type IV secretion
system required for transport of CagA (
cytotoxin
associated
gene) across the host cell membrane (
8,
29,
33). Once inside
the host cell, CagA is tyrosine phosphorylated, after which
it interrupts host signal transduction (
24) and induces a rearrangement
of the actin cytoskeleton (
33,
34). Most of the genes required
to translocate CagA are also required to induce gastric epithelial
cells to produce interleukin-8 (IL-8), which promotes inflammation
by recruitment of polymorphonuclear leukocytes to the gastric
epithelium (
7,
20). Other gene products that are recognized
to have an important role in
H. pylori pathogenesis include
urease (
18), flagella (
31), vacuolating cytotoxin (
27), and
a large family of outer membrane proteins, some of which function
as adhesins (
5,
44).
A further understanding of H. pylori pathogenesis requires analysis of the relative expression and conditions of expression for the Cag PAI and other major virulence determinants. Such an analysis may lead to the identification of bacterial factors that play a role in development of disease and help us to understand why some strains cause disease while others do not. It may also provide guidance for selection of drug targets or vaccine candidates, since most bacteria express virulence factors in a carefully regulated fashion. Although gene regulation by classical, two-component systems is probably less common in H. pylori than in organisms with an environmental niche as part of their life cycle, other methods of regulation, such as phase variation (45), are likely important. Since it is impossible to fully mimic in vitro the environmental conditions of infection in the host, it will be important to study in vivo expression directly in a relevant animal as well as in culture.
The rhesus monkey model is a relevant and tractable system for the study of H. pylori pathogenesis (15). Socially housed animals are naturally infected with H. pylori isolates that are nearly identical to human isolates (14, 16, 38). Infection is characterized by chronic gastritis and infiltration of polymorphonuclear leukocytes. Some infected monkeys develop atrophic gastritis, which is the histological precursor to gastric adenocarcinoma (15). Derivation of specific-pathogen (H. pylori)-free macaques by isolating them at birth provides a ready source of animals for experimental infection (37). The rhesus monkey model therefore provides an opportunity to investigate H. pylori gene expression after experimental infection under carefully controlled conditions.
In this study we describe the use of quantitative real-time reverse transcriptase PCR (qRT-PCR) to analyze gene expression from bacterial cells grown in vitro and from small amounts of bacterial RNA recovered from gastric biopsy specimens of experimentally infected macaques. Expression levels of 46 known or putative virulence genes were analyzed, which provides a transcript profile of gene expression during in vitro growth and during acute infection in the rhesus monkey.

MATERIALS AND METHODS
Bacterial strain and culture.
H. pylori J166 contains a functional Cag PAI and the s1m1 allele
of the
vacA cytotoxin (
39). Recent studies by us (
39) and others
(
15) showed that
H. pylori J166 preferentially colonizes rhesus
monkeys. Plate-grown bacteria were cultivated on brucella agar
(Difco Laboratories, Detroit, MI) containing 5% bovine calf
serum (GibcoBRL, Gaithersburg, MD) supplemented with TVPA (trimethoprim,
5 mg/liter; vancomycin, 10 mg/liter; polymixin B, 2.5 IU/liter;
amphotericin B, 4 mg/liter; all from Sigma, St. Louis, MO) and
incubated at 37°C in an atmosphere that contained 5% CO
2.
For liquid cultures, bacteria were grown in brucella broth containing
5% bovine calf serum with TVPA and incubated at 37°C with
5% CO
2 and gentle rotation at 60 rpm. Duplicate cultures were
inoculated to an optical density at 600 nm (OD
600) of 0.05 with
an overnight starter culture. OD
600 was determined serially
for each culture from 6 to 23.5 h after inoculation.
Animals.
Five specific-pathogen-free rhesus macaques (two males and three females) between the ages of 3 to 4 years were located at the California National Primate Research Center (CNPRC), which is accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care. All animals were confirmed to be free of H. pylori and "Candidatus Helicobacter heilmannii" (30) according to protocols described previously (37). Monkeys were housed indoors in separate cages throughout the course of the experiment. All procedures were approved by the CNPRC Research Advisory Committee and by the University of California, Davis, Chancellor's Animal Use and Care Administrative Advisory Committee.
Animal inoculations.
A 50-ml liquid culture of H. pylori J166 was cultivated as above for 19 h to an OD600 of approximately 0.2. The culture was centrifuged and resuspended in fresh brucella broth to an OD600 of 1.0. Each monkey was inoculated orogastrically with 7.5 x 108 CFU/1.5 ml. The inoculum was examined by Gram stain, urease, and oxidase tests to ensure a pure culture of H. pylori.
Biopsies and quantitative cultures.
Each monkey was biopsied at 1 week and 1, 2, 3, 4, and 6 months postinoculation (p.i.) using a pediatric gastroscope (Pentax FG-16X) with a 1.8-mm biopsy forceps. The procedure was performed under ketamine anesthesia (10 mg/kg of body weight intramuscularly) after an overnight fast. Eight antral biopsy specimens were collected from the stomach during each endoscopy. Six antral biopsy specimens were individually placed immediately in 200 µl Trizol (GibcoBRL) and put on ice. Two antral biopsy specimens were placed in 250 µl brucella broth for quantitative culture. Biopsy specimens were homogenized with a sterile glass rod before plating and RNA extractions. The 2 antral biopsy specimens in brucella broth were serially diluted, plated onto brucella agar supplemented with 5% bovine calf serum and TVPA, and incubated at 37°C with 5% CO2 for 5 to 6 days. H. pylori colonies were identified in the conventional manner by colony morphology, microscopy, and biochemistry. CFU were counted and CFU/g of tissue were determined for each monkey. Individual isolates were passed and frozen at 80°C in brucella broth containing 20% (vol/vol) glycerol.
RNA extraction.
At each OD600 determination, 2-ml aliquots were removed from the liquid cultures and centrifuged in a table top Microfuge for 30 s. The supernatant was removed, and 1 ml of Trizol was immediately added. Samples were vortexed, and RNA was extracted according to the manufacturer's directions. RNA was treated with DNase I (Roche Applied Science, Mannheim, Germany), purified using an RNeasy clean up kit (QIAGEN, Inc., Valencia, CA), and suspended in molecular biology grade water (BioWhittaker, Rockland, ME) at a concentration of 20 ng/µl. Samples were stored at 80°C prior to analysis. Total RNA was extracted from the six antral biopsy specimens using the Trizol protocol according to the manufacturer's instructions. RNA was treated with DNase I and purified using an RNeasy clean up kit. Purified RNA was suspended in 200 µl molecular biology grade water (BioWhittaker), diluted 1:5, and stored at 80°C prior to analysis.
DNA fingerprinting.
Repetitive extragenic palindromic PCR (Rep-PCR) was used to type strains recovered from each monkey at 1 week and at 1 and 2 months p.i. using methods previously described (22). Chromosomal DNA was prepared from plate-grown cells using the cetyltrimethylammonium bromide method (6). Degenerate oligonucleotide primers (50 pmol each) REP1R-Dt (5'-IIINCGNCGNCATCNGGC-3') and REP2-Dt (5'-NCGNCTTATCNGGCCTAC-3') were added to a 25-µl PCR that contained 100 ng of template DNA, 6 mM MgCl2, 0.6 mM concentrations of each deoxynucleoside triphosphates, and 2 units AmpliTaq DNA polymerase (Applied Biosystems, Foster City, CA). Amplification conditions were initial denaturation at 94°C for 2 min, 30 PCR cycles (94°C for 30 s, 45°C for 1 min, and 72°C for 3 min), and a single extension of 72°C for 5 min. PCR products were separated on 1.5% agarose gels, and fragments were visualized by ethidium bromide staining.
Primer design.
Gene-specific oligonucleotide primer pairs were utilized from a previous experiment (10), and new ones were designed for additional genes (Table 1) using Oligo 6.0 software (Molecular Biology Insights, Cascade, CO) and the known genome sequences of H. pylori 26695 (44) and J99 (3). All primer pairs had a calculated melting temperature of 68 to 70°C, amplified products between 100 to 300 bp, and ended with a double dA 3' terminus homologous to the template (36). Every primer pair was first used to amplify DNA from H. pylori J166, and the predicted amplicon size was verified by agarose gel electrophoresis prior to RT-PCR.
qRT-PCR.
qRT-PCR was performed with gene-specific primer pairs (Table
1) using methods previously described (
10). Briefly, RT and
PCR were performed in a single 20-µl reaction mixture
using the thermostable recombinant
Tth (r
Tth) DNA polymerase
(Applied Biosystems), which in the presence of Mn(OAc)
2 has
reverse transcriptase activity and DNA polymerase activity.
The RNA template was either 100 ng RNA from in vitro-grown cells
or a 1:5 dilution of in vivo RNA. To eliminate PCR carryover
contamination, each reaction mixture also included 0.4 U uracil-DNA-glycosylase
(New England Biolabs, Beverly, MA). A two-step amplification
was performed for 45 cycles at 95°C for 20 s followed by
59.5°C for 1 min. Accumulation of PCR product was detected
during each cycle by excitation of SYBR green at 490 nM. Relative
fluorescence was characterized by a cycle threshold (
Ct) value,
which was defined by the crossover point of the kinetic curve
with an arbitrary fluorescence level set at 150 relative fluorescence
units. The absence of contaminating DNA was examined by performing
the RT-PCR with 2.4 mM MgCl
2, in which r
Tth has DNA polymerase
but no RT activity. If the observed
Ct with RNA template was
not at least 2 cycles less than that of the no-template control
(water), the primer pair was eliminated from the analysis.
Primer efficiency.
Since even primer pairs with 100% homology to their template can amplify with markedly different efficiencies, we first tested primer pairs with H. pylori J166 DNA. Assuming there is one DNA copy per cell for each amplified gene, a Ct was determined and used to calculate the primer efficiency. In our laboratory, efficient amplification of 105 bacterial cell equivalents of DNA (0.186 ng) yielded a Ct equal to 18.5, which was arbitrarily defined as 97% efficiency. A primer pair with 97% efficiency would give a standard yield equal to 1.9418.5 copies after 18.5 cycles of PCR. Therefore, cycle efficiency as a function of the Ct observed for each primer pair can be defined as:
If the observed
Ct for a primer pair is 18.5, then
the cycle efficiency is 97%; higher
Ct values yield lower cycle
efficiencies. Only primer pairs with efficiencies of 90% or
better were used. Corrected
Ct, which takes into account primer
efficiency, can be determined from the following equation, where
cycle yield = 2
x cycle efficiency:
Calculation of absolute gene expression in vitro.
Copies per cell were calculated based on three factors: (i) a 10-fold change in starting template concentration corresponds to a change in Ct of 3.3 cycles, (ii) the assumption that 100 ng of RNA equals 106 H. pylori cells, (iii) the empirically derived observation that a Ct of 18.5 corresponds to 1 x 105 copies of starting DNA template (assuming 1 copy on the chromosome). For example, an observed Ct of 18.5 for a primer pair with 97% efficiency is calculated as 0.1 mRNA copies/cell. Since the starting amount of RNA template (100 ng) represents 106 bacterial cells, a Ct of 18.5 for RNA indicates 10-fold less starting template per cell than the same Ct observed with DNA, which is performed with 105 cell equivalents. Since a 10-fold change in template concentration corresponds (with efficient amplification) to 3.3 cycles (23.3 = 10), we calculate absolute gene expression as:
We have previously shown that calculation
of mRNA copies/cell using
Ct corrected for primer efficiency
yields values that are essentially identical to those obtained
by the more conventional method using standard curves (
10).
Calculation of relative gene expression in vivo.
Absolute gene expression could not be calculated for in vivo samples because the number of bacterial cells in each sample was unknown. Therefore, to account for differences in bacterial load among animals, all Ct values were normalized to the Ct of H. pylori 16S rRNA for each monkey sample. Data were therefore expressed as:

RESULTS AND DISCUSSION
Primer efficiency and control samples.
All 46 primer pairs amplified
H. pylori J166 DNA with at least
90% efficiency. Single bands were detected for each primer pair,
and the predicted amplicon length was verified on agarose gels
(data not shown). No signal was detected when qRT-PCR was performed
with control tissue from uninfected primates nor when Mn(OAc)
2 was replaced with 2.4 mM MgCl
2, in which r
Tth has DNA polymerase
activity but no RT activity (negative control).
In vitro gene expression. (i) Transcript copies/cell at mid-log growth.
Calculation of mRNA copies/cell at mid-log-phase growth (15 h; OD600, 1.0) showed that transcript levels of virulence genes varied by 4 orders of magnitude (Fig. 1A), ranging from 0.004 to almost 20 copies/cell. Expression of ureA and ureB was the highest, with nearly identical amounts of transcript. This was expected, since urease is one of the most abundant proteins found in H. pylori (26) and the genes are transcribed on a single operon. Expression levels of ureG and ureI were approximately 10- and 100-fold lower than that of ureAB, respectively. These accessory urease genes are thought to be transcribed on a second operon that consists of ureIEFGH. However, the steady-state level of message from individual genes is complex because both the amount and size of mRNAs from this operon are thought to be affected by a pH-dependent posttranscriptional regulatory mechanism (1). Also among the most highly expressed genes were napA, vacA, and babA (omp28), the ABO blood group adhesin (5). NapA was originally described as a promoter of neutrophil adhesion to endothelial cells (19). It was subsequently shown to be a multifunctional protein related to bacterioferritins and to the Escherichia coli Dps, a nonspecific DNA-binding protein that is induced by environmental stress and probably protects DNA from oxidative damage (9, 13). It seems likely that NapA and VacA, which was shown recently to inhibit H. pylori-specific T-lymphocyte activation (21, 41), are both critical for avoiding innate and adaptive host immunity and maintaining chronic infection. Transcript levels for genes on the Cag PAI also varied by more than 4 orders of magnitude (Fig. 1B), ranging from 0.001 (cag15) to 22 (cag25) copies/cell. There was no apparent relationship between expression level and whether a gene on the PAI is required for CagA tyrosine phosphorylation or induction of IL-8.
(ii) Growth-phase-dependent gene expression.
Growth curves for the duplicate
H. pylori cultures were nearly
identical (Fig.
2). Therefore, we combined the
Ct values determined
independently from each culture to calculate a mean copy/cell
(Fig.
2).
Ct values for 16S rRNA varied by less than twofold
during the growth curve. The change in gene expression during
the growth cycle was expressed as a ratio of mRNA copies/cell
at each time point relative to that at 6 h. From late-log-phase
(18 h; OD
600, 1.4) to stationary-phase (23.5 h; OD
600, 1.8)
growth, most genes (61%) showed a decrease in expression, though
expression increased in some cases (15%). Genes with a change
in expression of

2-fold are listed in Table
2. Of the 7 genes
whose expression was induced, most were also found by whole-genome
DNA microarray analysis to be induced by entry into stationary-phase
growth (
43) and by iron starvation (
28). Among the induced genes
were
napA and
katA, which likely play an important role in protection
against oxidative DNA damage during starvation or other environmental
stress. There was little correspondence between the genes whose
expression we found to be reduced during stationary phase and
the results from DNA microarray studies (
28,
43). This may in
part reflect the fact that repressed genes were expressed at
a lower level than induced genes (Table
2) and may have been
below the level of detection of the DNA microarray.
In vivo gene expression. (i) Quantitative culture and Rep-PCR.
Two antral biopsy specimens were used to determine quantitative
bacterial load from each monkey at 1 week and 1, 2, 3, 4, and
6 months p.i. At 1 week p.i., all 5 monkeys were infected with
5
x 10
4 to 4
x 10
7 CFU/g of tissue. However, between 1 and 6
months p.i., only 1 monkey remained infected with a bacterial
load that was sufficient for transcript quantitation. This was
likely due to the fact that the inoculum was grown from a single
colony, whereas we have previously used a mixture of 6 rhesus-passaged
J166 strains (
39). A mixed inoculum probably contains greater
genomic diversity that more efficiently colonizes multiple hosts
(
23). Similar observations have recently been made with the
mouse model (
17). Agarose gel electrophoresis of the Rep-PCR
products showed that the output strains from each monkey were
identical to the input J166 and differed from representative
strains of
H. pylori that are enzootic in socially housed rhesus
monkeys at the CNPRC (Fig.
3). These results confirm that our
expression data reflect infection with the inoculated strain
(J166) and not naturally acquired infection.
To provide an estimate of bacterial load, we normalized the
Ct for in vivo expression to that for 16S rRNA. We therefore
compared the quantitative culture results to the
Ct for 16S
rRNA (Fig.
4). The results showed a close correspondence between
CFU/g and
Ct over a broad range of bacterial load, with a Pearson
product correlation coefficient of 0.80. Since quantitative
culture of
H. pylori from gastric biopsy specimens lacks sensitivity,
with a detection limit of 10
2 to 10
3 CFU/g of tissue, qRT-PCR
can be used as a more accurate measure of infection when bacterial
load is low. For genes with high expression levels, it may sometimes
be possible to reliably quantitate gene expression from biopsy
specimens that are negative by culture but which are positive
by qRT-PCR for 16S rRNA.
(ii) Relative gene expression at 1 week p.i.
To account for differences in bacterial load, all
Ct values
were normalized to the
Ct of 16S rRNA for each animal, which
was 1.0 by definition. Since 16S rRNA is more abundant than
bacterial message, relative expression ranged from 0 to 1. Expression
levels for most genes represent mean data from the results from
5 animals, though in some cases, due to low bacterial load,
expression could only be determined from 3 or 4 animals. Relative
gene expression of the virulence and Cag PAI genes was between
1 and 5 logs lower than 16S rRNA (Fig.
5A and B). Genes that
were highly expressed in vitro, such as
ureA,
ureB,
napA,
cag1,
and
cag25, were also the most highly expressed genes in vivo.
The lowest expression among the Cag PAI genes was
cag22, which
is required for IL-8 induction and CagA translocation (
20).
This suggests that even expression levels more than 4 orders
of magnitude lower than 16S rRNA are biologically relevant.
In vivo versus in vitro gene expression.
To identify genes that were induced or repressed in vivo, we
first compared expression in vitro at mid-log phase (15 h; OD
600,
1.0) to in vivo expression at 1 week p.i. Relative gene expression
for the in vitro data was calculated exactly as for the in vivo
data (see Materials and Methods). Gene expression was generally
lower in vivo compared to in vitro expression during mid-log
phase (Fig.
6A). The mean (±standard deviation) ratios
of in vivo to in vitro expression during mid-log phase were
0.34 (±0.36) and 0.24 (±0.23) for the virulence
and Cag PAI genes, respectively. We next compared in vivo expression
at 1 week p.i. to stationary-phase expression (23.5 h; OD
600,
1.8) in vitro (Fig.
6B). This analysis showed that 9 genes were
more highly expressed in vivo than in vitro (Fig.
6B). Of these,
6 genes (
cag5,
virB11,
cag7,
cag8,
cag9, and
cag10) are found
contiguously on the PAI (absent
cag6), are oriented with open
reading frames (ORFs) in the same direction, and are flanked
by genes (
cag4 and
cag11) whose ORFs are in the opposite direction
(Fig.
1B). Most of these genes are implicated by experimental
analysis (
32,
35,
42) or by sequence homology (
11) to form portions
of the type IV secretion pilus or its accessory proteins. In
addition, another gene that appeared induced in vivo (
comB8)
is thought to encode a portion of a second
H. pylori type IV
secretion system that is utilized for DNA uptake and is required
for competence (
25). These results suggest the possibility that
at least some of the genes encoding the
H. pylori type IV structural
pilus and its accessory proteins may form an operon that is
induced during growth in vivo.
In vivo gene expression over time.
We analyzed in vivo
H. pylori gene expression for one monkey
at 1 week and 2, 3, 4, and 6 months p.i. To simplify the analysis,
we grouped the data into early (1 week)-, mid (2 to 3 months)-,
and late (4 to 6 months)-acute-phase infection. Interestingly,
almost all genes that showed more than a twofold induction were
induced during early- to mid-acute-phase infection (between
1 week and 2 to 3 months p.i.) (Table
3). These genes included
outer membrane proteins (OMPs), superoxide dismutase, and Cag
PAI genes, which may all play a role in establishing the infection
and evading the initial host immune response. Early in infection,
we saw apparent repression of
babA (
omp28), which codes for
the ABO blood group binding adhesin (
5), and induction of
babB (
omp19), a gene encoding for a related OMP with unknown function.
However, we recently reported that infection of rhesus macaques
with
H. pylori J166 results in selection for strains that have
undergone a gene conversion, whereby
babA has been deleted and
replaced by a duplicated copy of
babB. Therefore, this apparent
change in expression of
H. pylori OMPs is mediated by genomic
recombination and not by regulation of expression in the conventional
sense. The apparent changes in
cag7 (
cagY) expression (Table
3) may also be mediated by genomic events, since
cag7 has extensive
repeats that mediate in-frame deletions and duplications (
4).
These findings emphasize that, particularly in
H. pylori, apparent
changes in expression may sometimes reflect modifications in
the genome rather than bacterial sensing of environmental signals
via traditional two-component regulatory systems.
Comparison of H. pylori gene expression in rhesus macaques and humans.
We recently used qRT-PCR to perform
H. pylori transcription
profiling in chronically infected human patients (
10). In general,
the results are similar to those described here, which further
validates the use of the macaque as a model of human infection.
The Pearson product correlation coefficient between in vivo
gene expression levels in humans and macaques was 0.89 (Fig.
7), and the trend line had a slope of 1.0. This is a striking
finding in view of the fact that these data were collected not
only from different host species but also from different bacterial
strains and at different time periods. The generally reduced
expression levels in vivo compared to in vitro also mimics the
results seen for humans. We cannot fully exclude the possibility
that this finding is spurious. For example, if extraction efficiency
for mRNA versus stable RNA is lower in vivo than it is in vitro,
we might incorrectly conclude that expression is lower in vivo.
If this were the case, the reduced extraction efficiency of
mRNA from in vivo samples might be particularly troublesome
for low-abundance message, which would lead us to conclude erroneously
that reduced expression in vivo was exaggerated for genes with
low transcript abundance. However, this is the opposite of what
we observed (Fig.
6B). Furthermore, the fact that the result
is robust over differences in host and bacterial strains suggests
that reduced expression in vivo for many (but not all) genes
reflects the biology of
H. pylori infection and is not an artifact
of the methods used here.
These results provide, for the first time, a quantitative fingerprint
of
H. pylori gene expression in vitro and in vivo in experimentally
infected nonhuman primates. Comparison of
H. pylori gene expression
in vivo to expression in vitro during stationary phase suggests
the possibility that some genes encoding the
H. pylori type
IV structural pilus and accessory proteins may form an operon
that is induced during growth in vivo.

ACKNOWLEDGMENTS
We thank Michael Syvanen for many helpful discussions.
This work was supported in part by Public Health Service grants AI42081, RR14298, and RR15293 from the National Institutes of Health.

FOOTNOTES
* Corresponding author. Present address: Department of Medicine, Division of Infectious Disease, 513 Parnassus Avenue, HSE 418/Box 0654, University of California, San Francisco, San Francisco, CA 94143. Phone: (415) 502-5731. Fax: (415) 476-9364. E-mail:
jennib{at}medicine.ucsf.edu.

Editor: V. J. DiRita

REFERENCES
1 - Akada, J. K., M. Shirai, H. Takeuchi, M. Tsuda, and T. Nakazawa. 2000. Identification of the urease operon in Helicobacter pylori and its control by mRNA decay in response to pH. Mol. Microbiol. 36:1071-1084.[CrossRef][Medline]
2 - Akopyants, N. S., S. W. Clifton, D. Kersulyte, J. E. Crabtree, B. E. Youree, C. A. Reece, N. O. Bukanov, E. S. Drazek, B. A. Roe, and D. E. Berg. 1998. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol. Microbiol. 28:37-53.[CrossRef][Medline]
3 - Alm, R. A., L. S. Ling, D. T. Moir, B. L. King, E. D. Brown, P. C. Doig, D. R. Smith, B. Noonan, B. C. Guild, B. L. deJonge, G. Carmel, P. J. Tummino, A. Caruso, M. Uria-Nickelsen, D. M. Mills, C. Ives, R. Gibson, D. Merberg, S. D. Mills, Q. Jiang, D. E. Taylor, G. F. Vovis, and T. J. Trust. 1999. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397:176-180.[CrossRef][Medline]
4 - Aras, R. A., W. Fischer, G. I. Perez-Perez, M. Crosatti, T. Ando, R. Haas, and M. J. Blaser. 2003. Plasticity of repetitive DNA sequences within a bacterial (type IV) secretion system component. J. Exp. Med. 198:1349-1360.[Abstract/Free Full Text]
5 - Aspholm-Hurtig, M., G. Dailide, M. Lahmann, A. Kalia, D. Ilver, N. Roche, S. Vikstrom, R. Sjostrom, S. Linden, A. Backstrom, C. Lundberg, A. Arnqvist, J. Mahdavi, U. J. Nilsson, B. Velapatino, R. H. Gilman, M. Gerhard, T. Alarcon, M. Lopez-Brea, T. Nakazawa, J. G. Fox, P. Correa, M. G. Dominguez-Bello, G. I. Perez-Perez, M. J. Blaser, S. Normark, I. Carlstedt, S. Oscarson, S. Teneberg, D. E. Berg, and T. Boren. 2004. Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science 305:519-522.[Abstract/Free Full Text]
6 - Ausubel, F. M. 1988. Current protocols in molecular biology. John Wiley & Sons, New York, N.Y.
7 - Backert, S., T. Schwarz, S. Miehlke, C. Kirsch, C. Sommer, T. Kwok, M. Gerhard, U. B. Goebel, N. Lehn, W. Koenig, and T. F. Meyer. 2004. Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer. Infect. Immun. 72:1043-1056.[Abstract/Free Full Text]
8 - Backert, S., E. Ziska, V. Brinkmann, U. Zimny-Arndt, A. Fauconnier, P. R. Jungblut, M. Naumann, and T. F. Meyer. 2000. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell. Microbiol. 2:155-164.[CrossRef][Medline]
9 - Barnard, F. M., M. F. Loughlin, H. P. Fainberg, M. P. Messenger, D. W. Ussery, P. Williams, and P. J. Jenks. 2004. Global regulation of virulence and the stress response by CsrA in the highly adapted human gastric pathogen Helicobacter pylori. Mol. Microbiol. 51:15-32.[CrossRef][Medline]
10 - Boonjakuakul, J. K., M. Syvanen, A. Suryaprasad, C. L. Bowlus, and J. V. Solnick. 2004. Transcription profile of Helicobacter pylori in the human stomach reflects its physiology in vivo. J. Infect. Dis. 190:946-956.[CrossRef][Medline]
11 - Camilli, A., D. T. Beattie, and J. J. Mekalanos. 1994. Use of genetic recombination as a reporter of gene expression. Proc. Natl. Acad. Sci. USA 91:2634-2638.[Abstract/Free Full Text]
12 - Censini, S., C. Lange, Z. Xiang, J. E. Crabtree, P. Ghiara, M. Borodovsky, R. Rappuoli, and A. Covacci. 1996. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93:14648-14653.[Abstract/Free Full Text]
13 - Cooksley, C., P. J. Jenks, A. Green, A. Cockayne, R. P. Logan, and K. R. Hardie. 2003. NapA protects Helicobacter pylori from oxidative stress damage, and its production is influenced by the ferric uptake regulator. J. Med. Microbiol. 52:461-469.[Abstract/Free Full Text]
14 - Drazek, E. S., A. Dubois, and R. K. Holmes. 1994. Characterization and presumptive identification of Helicobacter pylori isolates from rhesus monkeys. J. Clin. Microbiol. 32:1799-1804.[Abstract/Free Full Text]
15 - Dubois, A., D. E. Berg, E. T. Incecik, N. Fiala, L. M. Heman-Ackah, G. I. Perez-Perez, and M. J. Blaser. 1996. Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease. Infect. Immun. 64:2885-2891.[Abstract]
16 - Dubois, A., N. Fiala, L. M. Heman-Ackah, E. S. Drazek, A. Tarnawski, W. N. Fishbein, G. I. Perez-Perez, and M. J. Blaser. 1994. Natural gastric infection with Helicobacter pylori in monkeys: a model for spiral bacteria infection in humans. Gastroenterology 106:1405-1417.[Medline]
17 - Eaton, K. Abstr. 104th Gen. Meet. Am. Soc. Microbiol., abstr. D-213, 2004.
18 - Eaton, K. A., C. L. Brooks, D. R. Morgan, and S. Krakowka. 1991. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect. Immun. 59:2470-2475.[Abstract/Free Full Text]
19 - Evans, D. J., Jr., D. G. Evans, T. Takemura, H. Nakano, H. C. Lampert, D. Y. Graham, D. N. Granger, and P. R. Kvietys. 1995. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect. Immun. 63:2213-2220.[Abstract]
20 - Fischer, W., J. Puls, R. Buhrdorf, B. Gebert, S. Odenbreit, and R. Haas. 2001. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42:1337-1348.[CrossRef][Medline]
21 - Gebert, B., W. Fischer, E. Weiss, R. Hoffmann, and R. Haas. 2003. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301:1099-1102.[Abstract/Free Full Text]
22 - Go, M. F., K. Y. Chan, J. Versalovic, T. Koeuth, D. Y. Graham, and J. R. Lupski. 1995. Cluster analysis of Helicobacter pylori genomic DNA fingerprints suggests gastroduodenal disease-specific associations. Scand. J. Gastroenterol. 30:640-646.[Medline]
23 - Hansen, L. M., and J. V. Solnick. 2001. Selection for urease activity during Helicobacter pylori infection of rhesus macaques (Macaca mulatta). Infect. Immun. 69:3519-3522.[Abstract/Free Full Text]
24 - Higashi, H., R. Tsutsumi, S. Muto, T. Sugiyama, T. Azuma, M. Asaka, and M. Hatakeyama. 2002. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295:683-686.[Abstract/Free Full Text]
25 - Hofreuter, D., S. Odenbreit, and R. Haas. 2001. Natural transformation competence in Helicobacter pylori is mediated by the basic components of a type IV secretion system. Mol. Microbiol. 41:379-391.[CrossRef][Medline]
26 - Hu, L. T., and H. L. Mobley. 1990. Purification and N-terminal analysis of urease from Helicobacter pylori. Infect. Immun. 58:992-998.[Abstract/Free Full Text]
27 - Inui, T., S. Mizuno, K. Takai, M. Nakagawa, M. Uchida, M. Fujimiya, A. Asakawa, and A. Inui. 2003. Helicobacter pylori cytotoxin: a novel ligand for receptor-like protein tyrosine phosphatase beta. Int. J. Mol. Med. 12:917-921.[Medline]
28 - Merrell, D. S., L. J. Thompson, C. C. Kim, H. Mitchell, L. S. Tompkins, A. Lee, and S. Falkow. 2003. Growth phase-dependent response of Helicobacter pylori to iron starvation. Infect. Immun. 71:6510-6525.[Abstract/Free Full Text]
29 - Odenbreit, S., J. Puls, B. Sedlmaier, E. Gerland, W. Fischer, and R. Haas. 2000. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497-1500.[Abstract/Free Full Text]
30 - O'Rourke, J. L., J. V. Solnick, B. A. Neilan, K. Seidel, R. Hayter, L. M. Hansen, and A. Lee. 2004. Description of Candidatus Helicobacter heilmannii based on DNA sequence analysis of 16S rRNA and urease genes. Int. J. Syst. Evol. Microbiol. 54:2203-2211.[Abstract/Free Full Text]
31 - Ottemann, K. M., and A. C. Lowenthal. 2002. Helicobacter pylori uses motility for initial colonization and to attain robust infection. Infect. Immun. 70:1984-1990.[Abstract/Free Full Text]
32 - Rohde, M., J. Puls, R. Buhrdorf, W. Fischer, and R. Haas. 2003. A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system. Mol. Microbiol. 49:219-234.[CrossRef][Medline]
33 - Segal, E. D., J. Cha, J. Lo, S. Falkow, and L. S. Tompkins. 1999. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. USA 96:14559-14564.[Abstract/Free Full Text]
34 - Segal, E. D., S. Falkow, and L. S. Tompkins. 1996. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc. Natl. Acad. Sci. USA 93:1259-1264.[Abstract/Free Full Text]
35 - Selbach, M., S. Moese, T. F. Meyer, and S. Backert. 2002. Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect. Immun. 70:665-671.[Abstract/Free Full Text]
36 - Sninsky, J. J., M. A. Innis, and D. H. Gelfand. 1999. PCR applications: protocols for functional genomics. Academic Press, San Diego, Calif.
37 - Solnick, J. V., D. R. Canfield, S. Yang, and J. Parsonnet. 1999. Rhesus monkey (Macaca mulatta) model of Helicobacter pylori: noninvasive detection and derivation of specific-pathogen-free monkeys. Lab. Anim. Sci. 49:197-201.[Medline]
38 - Solnick, J. V., K. Chang, D. R. Canfield, and J. Parsonnet. 2003. Natural acquisition of Helicobacter pylori infection in newborn rhesus macaques. J. Clin. Microbiol. 41:5511-5516.[Abstract/Free Full Text]
39 - Solnick, J. V., L. M. Hansen, D. R. Canfield, and J. Parsonnet. 2001. Determination of the infectious dose of Helicobacter pylori during primary and secondary infection in rhesus monkeys (Macaca mulatta). Infect. Immun. 69:6887-6892.[Abstract/Free Full Text]
40 - Suerbaum, S., and P. Michetti. 2002. Helicobacter pylori infection. N. Engl. J. Med. 347:1175-1186.[Free Full Text]
41 - Sundrud, M. S., V. J. Torres, D. Unutmaz, and T. L. Cover. 2004. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc. Natl. Acad. Sci. USA 101:7727-7732.[Abstract/Free Full Text]
42 - Tanaka, J., T. Suzuki, H. Mimuro, and C. Sasakawa. 2003. Structural definition on the surface of Helicobacter pylori type IV secretion apparatus. Cell. Microbiol. 5:395-404.[CrossRef][Medline]
43 - Thompson, L. J., D. S. Merrell, B. A. Neilan, H. Mitchell, A. Lee, and S. Falkow. 2003. Gene expression profiling of Helicobacter pylori reveals a growth-phase-dependent switch in virulence gene expression. Infect. Immun. 71:2643-2655.[Abstract/Free Full Text]
44 - Tomb, J. F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Fitzegerald, N. Lee, M. D. Adams, J. C. Venter, et al. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-547.[CrossRef][Medline]
45 - van der Woude, M. W., and A. J. Baumler. 2004. Phase and antigenic variation in bacteria. Clin. Microbiol. Rev. 17:581-611.[Abstract/Free Full Text]
Infection and Immunity, August 2005, p. 4895-4904, Vol. 73, No. 8
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.8.4895-4904.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Castillo, A. R., Woodruff, A. J., Connolly, L. E., Sause, W. E., Ottemann, K. M.
(2008). Recombination-Based In Vivo Expression Technology Identifies Helicobacter pylori Genes Important for Host Colonization. Infect. Immun.
76: 5632-5644
[Abstract]
[Full Text]
-
Peek, R. M. Jr
(2008). Helicobacter pylori infection and disease: from humans to animal models. DMM
1: 50-55
[Abstract]
[Full Text]
-
Krishnan, N., Doster, A. R., Duhamel, G. E., Becker, D. F.
(2008). Characterization of a Helicobacter hepaticus putA Mutant Strain in Host Colonization and Oxidative Stress. Infect. Immun.
76: 3037-3044
[Abstract]
[Full Text]
-
Kutter, S., Buhrdorf, R., Haas, J., Schneider-Brachert, W., Haas, R., Fischer, W.
(2008). Protein Subassemblies of the Helicobacter pylori Cag Type IV Secretion System Revealed by Localization and Interaction Studies. J. Bacteriol.
190: 2161-2171
[Abstract]
[Full Text]
-
Skoglund, A., Bjorkholm, B., Nilsson, C., Andersson, A. F., Jernberg, C., Schirwitz, K., Enroth, C., Krabbe, M., Engstrand, L.
(2007). Functional Analysis of the M.HpyAIV DNA Methyltransferase of Helicobacter pylori. J. Bacteriol.
189: 8914-8921
[Abstract]
[Full Text]
-
Scott, D. R., Marcus, E. A., Wen, Y., Oh, J., Sachs, G.
(2007). Gene expression in vivo shows that Helicobacter pylori colonizes an acidic niche on the gastric surface. Proc. Natl. Acad. Sci. USA
104: 7235-7240
[Abstract]
[Full Text]
-
Busler, V. J., Torres, V. J., McClain, M. S., Tirado, O., Friedman, D. B., Cover, T. L.
(2006). Protein-Protein Interactions among Helicobacter pylori Cag Proteins. J. Bacteriol.
188: 4787-4800
[Abstract]
[Full Text]